World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
48719
World Ranking
8443
National Ranking
96

Leo Niskanen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Leo Niskanen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 393 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Leo Niskanen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Leo Niskanen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Leo Niskanen is affiliated with the University of Helsinki in Finland. Their research primarily focuses on the field of Medicine, with a significant concentration in Endocrinology, Diabetes and Metabolism. In addition, their work encompasses Surgery, Nephrology, Epidemiology, and Molecular Biology as notable subfields.

The scientist's main topics of study include:

  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Dialysis and Renal Disease Management
  • Diabetes and associated disorders
  • Chronic Kidney Disease and Diabetes

Leo Niskanen has contributed to publications in a variety of journals, with frequent venues including:

  • Primary care diabetes
  • International Urology and Nephrology
  • The Lancet Diabetes & Endocrinology
  • JAMA Network Open
  • Diabetes & Metabolism

Recent papers authored or coauthored by Niskanen include:

  • Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial (2021, The Lancet Diabetes & Endocrinology)
  • Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery (2022, JAMA Network Open)
  • Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study (2023, Diabetes & Metabolism)
  • Oral health associated with incident diabetes but not other chronic diseases: A register-based cohort study (2022, Frontiers in Oral Health)
  • The majority of type 2 diabetic patients in Finnish primary care are at very high risk of cardiovascular events: A cross-sectional chart review study (STONE HF) (2021, Primary care diabetes)

Their frequent coauthors include:

  • Tomi-Pekka Tuomainen
  • Mounir Ould Setti
  • Jari Haukka
  • Thomas Nyström
  • Avraham Karasik

Best Publications

  • THE METABOLIC SYNDROME AND TOTAL AND CARDIOVASCULAR DISEASE MORTALITY IN MIDDLE-AGED MEN

    Hanna-Maaria Lakka;David E. Laaksonen;Timo A. Lakka;Leo K. Niskanen

  • Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

    Lennart Hansson;Lars H Lindholm;Leo Niskanen;Jan Lanke

  • 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

    Jari Tiihonen;Jari Tiihonen;Jouko Lönnqvist;Kristian Wahlbeck;Timo Klaukka

  • Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

    Arne Astrup;Stephan Rössner;Luc Van Gaal;Aila Rissanen

  • Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

    David E. Laaksonen;Hanna-Maaria Lakka;Leo K. Niskanen;George A. Kaplan

  • Testosterone and Sex Hormone–Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men

    David E. Laaksonen;Leo Niskanen;Kari Punnonen;Kristiina Nyyssönen

  • Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-Aged Men: A Prospective Cohort Study

    Leo K. Niskanen;David E. Laaksonen;Kristiina Nyyssönen;Georg Alfthan

  • Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

    Juhani Partanen;Leo Niskanen;Juha Lehtinen;Esa Mervaala

  • Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.

    David E. Laaksonen;Hanna-Maaria Lakka;Jukka T. Salonen;Leo K. Niskanen

  • Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

    William T Cefalu;William T Cefalu;Lawrence A Leiter;Kun-Ho Yoon;Pablo Arias

  • Physical Activity in the Prevention of Type 2 Diabetes The Finnish Diabetes Prevention Study

    David E. Laaksonen;Jaana Lindström;Timo A. Lakka;Johan G. Eriksson

  • Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.

    A Astrup;R Carraro;N Finer;A Harper

  • Medial Artery Calcification A Neglected Harbinger of Cardiovascular Complications in Non–Insulin-Dependent Diabetes Mellitus

    Seppo Lehto;Leo Niskanen;Matti Suhonen;Tapani Rönnemaa

  • Sex hormones, inflammation and the metabolic syndrome: a population-based study.

    David E. Laaksonen;Leo Niskanen;Kari Punnonen;Kristiina Nyyssönen

  • Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome.

    Timo A. Lakka;David E. Laaksonen;Hanna Maaria Lakka;Niko Männikkö

  • Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

    M. I. J. Uusitupa;L. K. Niskanen;O. Siitonen;E. Voutilainen

  • Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus

    Seppo Lehto;Leo Niskanen;Tapani Rönnemaa;Markku Laakso

  • Comparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes Mellitus

    H Yki-Järvinen;M Kauppila;E Kujansuu;J Lahti

  • Inflammation, Abdominal Obesity, and Smoking as Predictors of Hypertension

    Leo Niskanen;David E. Laaksonen;Kristiina Nyyssönen;Kari Punnonen

  • Age and gender dependency of baroreflex sensitivity in healthy subjects

    Tomi Laitinen;Juha Hartikainen;Esko Vanninen;Leo Niskanen

Frequent Co-Authors

Heimo Viinamäki
Heimo Viinamäki University of Eastern Finland
Matti Uusitupa
Matti Uusitupa University of Eastern Finland
Markku Laakso
Markku Laakso University of Eastern Finland
Jari Haukka
Jari Haukka University of Helsinki
Sirkka Keinänen-Kiukaanniemi
Sirkka Keinänen-Kiukaanniemi Oulu University Hospital
Kirsi Honkalampi
Kirsi Honkalampi University of Eastern Finland
Karl-Heinz Herzig
Karl-Heinz Herzig Oulu University Hospital
Markku Peltonen
Markku Peltonen Finnish Institute for Health and Welfare (THL)
Rainer Rauramaa
Rainer Rauramaa University of Eastern Finland
Jukka T. Salonen
Jukka T. Salonen University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA offers diverse paths beyond traditional MD programs. Online degrees in nursing and healthcare are increasingly popular, providing flexibility for working professionals and those seeking career advancement.

Many registered nurses are now opting for best online rn to bsn programs without clinical requirements, saving time and allowing students to balance studies with work. For those aspiring to advance further, options such as accelerated msn to dnp programs open doors to leadership and specialized roles within healthcare.

Cost remains a significant factor for many students. Fortunately, affordable dnp programs make doctoral-level nursing education more accessible, helping reduce student debt while providing advanced skills. For those entering the field, lpn programs offer a fast-track entry into healthcare, equipping graduates for key support roles in patient care.

These online pathways offer flexibility, affordability, and new opportunities for those interested in medical careers or looking to upskill within the field.

Best Scientists Citing Leo Niskanen

Trending Scientists

Recently Published Articles